comera_logo_rgb.png
Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
November 17, 2022 16:05 ET | Comera Life Sciences
WOBURN, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to...
comera_logo_rgb.png
Comera Life Sciences Reports Financial Results for Third Quarter 2022 and Business Highlights
November 10, 2022 08:00 ET | Comera Life Sciences
– Extended and broadened its ongoing research collaboration with Regeneron, a leading U.S. biotechnology company – – Announces CLS-001 as subcutaneous formulation of vedolizumab, a currently marketed...
comera_logo_rgb.png
Comera Life Sciences Appoints Janice Marie McCourt as Chief Business Officer
November 09, 2022 08:00 ET | Comera Life Sciences
WOBURN, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to...
comera_logo_rgb.png
Comera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 Study
October 18, 2022 08:00 ET | Comera Life Sciences
WOBURN, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to...
comera_logo_rgb.png
Comera Life Sciences Expands Woburn Operations
October 04, 2022 10:30 ET | Comera Life Sciences
Elected Officials, Industry Leaders Celebrate Biotech Workforce Growth at Ribbon-Cutting Event WOBURN, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a...
comera_logo_rgb.png
Comera Life Sciences Announces Up To $15 million Purchase Agreement with Arena Business Solutions
August 31, 2022 16:15 ET | Comera Life Sciences
WOBURN, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life sciences company developing a new generation of bio-innovative...
comera_logo_rgb.png
Comera Life Sciences to Present Topline Results of SEQURUS-2 Study at 14th Annual Bioprocessing Summit
August 11, 2022 08:00 ET | Comera Life Sciences
WOBURN, Mass., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life sciences company developing a new generation of bio-innovative...
comera_logo_rgb.png
Comera Life Sciences Provides Business Highlights and Reports Financial Results for the Second Quarter 2022
August 10, 2022 16:15 ET | Comera Life Sciences
WOBURN, Mass., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to...
comera_logo_rgb.png
Comera Life Sciences Announces Favorable Preclinical Topline Safety Results of Lead SQore Excipient
July 13, 2022 08:00 ET | Comera Life Sciences
WOBURN, Mass., July 13, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to...